DERMAPEX

Serial Number 98250184
606

Registration Progress

Application Filed
Nov 1, 2023
Under Examination
Jun 18, 2024
Approved for Publication
Apr 23, 2024
Published for Opposition
Apr 23, 2024
Registered

Basic Information

Serial Number
98250184
Filing Date
November 1, 2023
Published for Opposition
April 23, 2024
Abandonment Date
January 20, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 20, 2025
Classes
005

Rights Holder

PHIO PHARMACEUTICALS CORP.

03
Address
Suite 101
257 Simarano Drive
Marlborough, MA 01752

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 606

Ownership History

PHIO PHARMACEUTICALS CORP.

Original Applicant
03
Marlborough, MA

PHIO PHARMACEUTICALS CORP.

Owner at Publication
03
Marlborough, MA

Legal Representation

Attorney
Robert S. Silver

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description
Jan 20, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 20, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jun 18, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 PUBO A PUBLISHED FOR OPPOSITION
Apr 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2024 DOCK D ASSIGNED TO EXAMINER
Nov 16, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical compositions for the treatment of cancer

Classification

International Classes
005